The global mucopolysaccharidosis (mps) treatment market was valued at approximately USD 4.4 billion in 2025 and is projected to reach USD 11 billion by 2035, growing at a CAGR of 10.8% during the forecast period. The market growth reflects increasing awareness of rare lysosomal storage disorders, rising adoption of enzyme replacement therapies, and innovations in gene therapy targetin... https://www.researchnester.com/reports/mucopolysaccharidosis-treatment-market/5215